contraindications for glp 1 medications Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Adverse Effects of GLP-1 Receptor
Description
Freezing is equally destructive
Novo Nordisks Wegovy, for example, recently showed a 20% reduction to incidence of heart attack, stroke, or death from heart disease
It contains the active ingredient liraglutide, but unlike Mounjaro and Wegovy, it requires daily injection
El anlisis reciente revel que solo el 8 % de los pacientes que comenzaron un tratamiento con agonistas del pptido similar al glucagn-1 (GLP-1) contra la obesidad sin diabetes mantienen la terapia luego de tres aos
Recent Developments: In Mar 2025, CordenPharma launched a greenfield peptide manufacturing plant in Basel, Switzerland, into operation
Acknowledgements: The authors thank Steven Lamberti, MD, for his critical advice and review of the manuscript
